FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146405701> ?p ?o ?g. }

• W2146405701 endingPage "5314" @default.
• W2146405701 startingPage "5306" @default.
• W2146405701 abstract "ABSTRACT Glycopeptides are known to select for heterogeneous vancomycin-intermediate Staphylococcus aureus (h-VISA) from susceptible strains. In certain clinical situations, h-VISA strains have been isolated from patients without previous exposure to glycopeptides, such as cystic fibrosis patients, who frequently receive repeated treatments with beta-lactam antibiotics. Our objective was to determine whether prolonged exposure to beta-lactam antibiotics can induce h-VISA. We exposed 3 clinical vancomycin-susceptible methicillin-resistant Staphylococcus aureus (MRSA) strains to ceftazidime, ceftriaxone, imipenem, and vancomycin (as a control) at subinhibitory concentrations for 18 days in vitro . Population analyses showed progressive increases in vancomycin resistance; seven of the 12 derived strains obtained after induction were classified as h-VISA according to the following criteria: area under the curve (AUC) on day 18/AUC of Mu3 of ≥90% and/or growth on brain heart infusion (BHI) agar with 4 mg/liter vancomycin. The derived isolates had thickened cell walls proportional to the level of glycopeptide resistance. Genes known to be associated with glycopeptide resistance ( vraSR , yvqF , SA1703, graRS , walKR , and rpoB ) were PCR sequenced; no de novo mutations were observed upon beta-lactam exposure. To determine whether trfA , a gene encoding a glycopeptide resistance factor, was essential in the selection of h-VISA upon beta-lactam pressure, a trfA -knockout strain was generated by allelic replacement. Indeed, beta-lactam exposure of this mutated strain showed no capacity to induce vancomycin resistance. In conclusion, these results showed that beta-lactam antibiotics at subinhibitory concentrations can induce intermediate vancomycin resistance in vitro . This induction required an intact trfA locus. Our results suggest that prior use of beta-lactam antibiotics can compromise vancomycin efficacy in the treatment of MRSA infections." @default.
• W2146405701 created "2016-06-24" @default.
• W2146405701 creator A5007105959 @default.
• W2146405701 creator A5021464020 @default.
• W2146405701 creator A5022125342 @default.
• W2146405701 creator A5030445089 @default.
• W2146405701 creator A5032287963 @default.
• W2146405701 creator A5046665088 @default.
• W2146405701 creator A5050558460 @default.
• W2146405701 creator A5057061671 @default.
• W2146405701 creator A5065171970 @default.
• W2146405701 creator A5069009054 @default.
• W2146405701 creator A5071115300 @default.
• W2146405701 creator A5078400899 @default.
• W2146405701 date "2014-09-01" @default.
• W2146405701 modified "2023-10-18" @default.
• W2146405701 title "Exposure of Staphylococcus aureus to Subinhibitory Concentrations of β-Lactam Antibiotics Induces Heterogeneous Vancomycin-Intermediate Staphylococcus aureus" @default.
• W2146405701 cites W1558571934 @default.
• W2146405701 cites W1985717850 @default.
• W2146405701 cites W1991106306 @default.
• W2146405701 cites W2004871459 @default.
• W2146405701 cites W2016091935 @default.
• W2146405701 cites W2028922754 @default.
• W2146405701 cites W2053081212 @default.
• W2146405701 cites W2055043387 @default.
• W2146405701 cites W2055414921 @default.
• W2146405701 cites W2061708150 @default.
• W2146405701 cites W2067652133 @default.
• W2146405701 cites W2080376709 @default.
• W2146405701 cites W2080999651 @default.
• W2146405701 cites W2082816719 @default.
• W2146405701 cites W2093989241 @default.
• W2146405701 cites W2098499925 @default.
• W2146405701 cites W2099065614 @default.
• W2146405701 cites W2099883798 @default.
• W2146405701 cites W2104377397 @default.
• W2146405701 cites W2111070278 @default.
• W2146405701 cites W2111993374 @default.
• W2146405701 cites W2115317294 @default.
• W2146405701 cites W2118094416 @default.
• W2146405701 cites W2121952186 @default.
• W2146405701 cites W2124205716 @default.
• W2146405701 cites W2125137652 @default.
• W2146405701 cites W2125270473 @default.
• W2146405701 cites W2126915534 @default.
• W2146405701 cites W2127747618 @default.
• W2146405701 cites W2129004019 @default.
• W2146405701 cites W2132909924 @default.
• W2146405701 cites W2137097355 @default.
• W2146405701 cites W2144963218 @default.
• W2146405701 cites W2157018267 @default.
• W2146405701 cites W2163780760 @default.
• W2146405701 cites W2165562761 @default.
• W2146405701 cites W2167770606 @default.
• W2146405701 doi "https://doi.org/10.1128/aac.02574-14" @default.
• W2146405701 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4135816" @default.
• W2146405701 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24957836" @default.
• W2146405701 hasPublicationYear "2014" @default.
• W2146405701 type Work @default.
• W2146405701 sameAs 2146405701 @default.
• W2146405701 citedByCount "32" @default.
• W2146405701 countsByYear W21464057012015 @default.
• W2146405701 countsByYear W21464057012016 @default.
• W2146405701 countsByYear W21464057012017 @default.
• W2146405701 countsByYear W21464057012018 @default.
• W2146405701 countsByYear W21464057012019 @default.
• W2146405701 countsByYear W21464057012020 @default.
• W2146405701 countsByYear W21464057012021 @default.
• W2146405701 countsByYear W21464057012022 @default.
• W2146405701 countsByYear W21464057012023 @default.
• W2146405701 crossrefType "journal-article" @default.
• W2146405701 hasAuthorship W2146405701A5007105959 @default.
• W2146405701 hasAuthorship W2146405701A5021464020 @default.
• W2146405701 hasAuthorship W2146405701A5022125342 @default.
• W2146405701 hasAuthorship W2146405701A5030445089 @default.
• W2146405701 hasAuthorship W2146405701A5032287963 @default.
• W2146405701 hasAuthorship W2146405701A5046665088 @default.
• W2146405701 hasAuthorship W2146405701A5050558460 @default.
• W2146405701 hasAuthorship W2146405701A5057061671 @default.
• W2146405701 hasAuthorship W2146405701A5065171970 @default.
• W2146405701 hasAuthorship W2146405701A5069009054 @default.
• W2146405701 hasAuthorship W2146405701A5071115300 @default.
• W2146405701 hasAuthorship W2146405701A5078400899 @default.
• W2146405701 hasBestOaLocation W21464057011 @default.
• W2146405701 hasConcept C137610392 @default.
• W2146405701 hasConcept C2776703206 @default.
• W2146405701 hasConcept C2776968632 @default.
• W2146405701 hasConcept C2777052132 @default.
• W2146405701 hasConcept C2777637488 @default.
• W2146405701 hasConcept C2778980435 @default.
• W2146405701 hasConcept C2779390152 @default.
• W2146405701 hasConcept C2779489039 @default.
• W2146405701 hasConcept C2779631663 @default.
• W2146405701 hasConcept C501593827 @default.
• W2146405701 hasConcept C523546767 @default.
• W2146405701 hasConcept C54355233 @default.
• W2146405701 hasConcept C86803240 @default.
• W2146405701 hasConcept C89423630 @default.

• next